132
Participants
Start Date
August 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
BIOD-123
Lispro (Humalog)
Research Foundation of SUNY Upstate Medical University, Syracuse
Diabetes & Glandular Disease Research, Rockville
Diabetes & Endocrinology Consultants, PC, Morehead City
Mountain Diabetes & Endrocrine Center, Dallas
Endocrine Research Solutions, Roswell
Progressive Medical Research Pharmaseek, Port Orange
The Center for Diabetes and Endocrine Care, Hollywood
University of Miami Diabetes Research Institute, Miami
Kentucky Diabetes, Lexington
Sentral Clinical Research Services, LLC, Cincinnati
Henry Ford Health System, Detroit
Mercury Street Medical, Butte
MidAmerica Diabetes Associates, PA, Wichita
Dallas Diabetes and Endocrine Research Center, Dallas
Research Institute of Dallas, Dallas
Baylor Endocrine Center, Dallas
Sonterra Clinical Research, San Antonio
Texas Diabetes and Endocrinology, Round Rock
Texas Diabetes and Endocrinology, Austin
Rocky Mountain Diabetes and Osteoporosis Center PA, Idaho Falls
Desert Endocrinolgy, Henderson
Providence Clinical Research Pharmaseek, North Hollywood
Profil Research Institute, Chula Vista
Scripps Whittier Diabetes Institute, La Jolla
Anaheim Clinical Trials, LLC, Anaheim
Monteagle Medical Center, San Francisco
Mills-Peninsula Health Services, San Mateo
John Muir Physician Network Clinical Research Center, Concord
Private Practice - Richard Cherlin, MD., Los Gatos
Oregon Health Sciences University, Portland
Capital Clinical Research Center, Olympia
Ranier Clinical Research, Inc, Renton
Rockwood Clinic, Spokane
Atlanta Diabetes Associates, Atlanta
Lead Sponsor
Biodel
INDUSTRY